BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37781040)

  • 1. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response.
    Zheng H; Wang M; Zhang S; Hu D; Yang Q; Chen M; Zhang X; Zhang Y; Dai J; Liou YC
    Int J Biol Sci; 2023; 19(14):4689-4708. PubMed ID: 37781040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors.
    Gao T; Zhao L; Zhang F; Cao C; Fan S; Shi X
    World J Surg Oncol; 2022 Jun; 20(1):207. PubMed ID: 35710427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.
    Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X
    Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma.
    Okamoto A; Higo M; Shiiba M; Nakashima D; Koyama T; Miyamoto I; Kasama H; Kasamatsu A; Ogawara K; Yokoe H; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(11):e0142252. PubMed ID: 26554377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer.
    Gou R; Zheng M; Hu Y; Gao L; Wang S; Liu O; Li X; Zhu L; Liu J; Lin B
    BMC Cancer; 2022 Jun; 22(1):690. PubMed ID: 35739489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of NUSAP1 in progression and expansion of glioblastoma multiforme.
    Qian Z; Li Y; Ma J; Xue Y; Xi Y; Hong L; Dai X; Zhang Y; Ji X; Chen Y; Sheng M; Sheng Y; Yang L; Liu J; Dai X; Shi J; Xie T; Dong J
    J Neurooncol; 2018 Nov; 140(2):199-208. PubMed ID: 29995176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
    Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
    Front Immunol; 2022; 13():837512. PubMed ID: 35401558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients.
    Zhu T; Xie P; Gao YF; Huang MS; Li X; Zhang W; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2018 Mar; 24(3):178-186. PubMed ID: 29336114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis.
    Tu Z; Peng J; Long X; Li J; Wu L; Huang K; Zhu X
    Front Immunol; 2022; 13():844736. PubMed ID: 35592314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SLC12A8 as a valuable prognostic biomarker and immunotherapeutic target by comprehensive pan-cancer analysis.
    Yu D; Ma H; Li D; Tang H; Li W; Li M
    Gene; 2024 Apr; 903():148211. PubMed ID: 38280496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
    Ling B; Wei P; Xiao J; Cen B; Wei H; Feng X; Ye G; Li S; Zhang Z; Liang W; Huang S; Huang W
    Oncol Rep; 2021 Mar; 45(3):1044-1058. PubMed ID: 33650655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.
    Ge Y; Li Q; Lin L; Jiang M; Shi L; Wang B; Yang L; Xu Z
    Cell Biochem Funct; 2020 Jan; 38(1):28-37. PubMed ID: 31710389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of NUSAP1 and Its Correlation with Immune Infiltrates in Human Breast Cancer.
    Li M; Yang B
    Crit Rev Eukaryot Gene Expr; 2022; 32(3):45-60. PubMed ID: 35695609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis.
    Sun L; Shi C; Liu S; Zhang E; Yan L; Ji C; Zhao Y
    Gene; 2020 Jul; 747():144657. PubMed ID: 32298762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of nucleolar and spindle-associated protein 1 expression suppresses cell migration, proliferation and invasion in renal cell carcinoma.
    Fang L; Zhang M; Chen L; Xiong H; Ge Y; Lu W; Wu X; Heng B; Yu D; Wu S
    Oncol Rep; 2016 Sep; 36(3):1506-16. PubMed ID: 27461786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01393, a Novel Long Non-Coding RNA, Promotes the Cell Proliferation, Migration and Invasion through MiR-128-3p/NUSAP1 Axis in Glioblastoma.
    Li D; Hu J; Li S; Zhou C; Feng M; Li L; Gao Y; Chen X; Wu X; Cao Y; Hao B; Chen L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar and spindle associated protein 1 promotes the aggressiveness of astrocytoma by activating the Hedgehog signaling pathway.
    Wu X; Xu B; Yang C; Wang W; Zhong D; Zhao Z; He L; Hu Y; Jiang L; Li J; Song L; Zhang W
    J Exp Clin Cancer Res; 2017 Sep; 36(1):127. PubMed ID: 28899410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.
    Pan B; Cheng J; Tan W; Wu X; Fan Q; Fan L; Jiang M; Yu R; Cheng X; Deng Y
    Aging (Albany NY); 2024 May; 16(9):8171-8197. PubMed ID: 38738999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
    Song J; Yang R; Wei R; Du Y; He P; Liu X
    Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.